Phillip Randolph Torralva
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$1.8MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 20, 2025 | NIH | SBIR Phase II Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model. | $447K | — |
| Mar 3, 2025 | NIH | SBIR Phase II Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model. | $100K | — |
| Feb 23, 2024 | NIH | SBIR Phase II Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model. | $523K | — |
| Sep 2, 2022 | NIH | SBIR Phase II Fentanyl induces naloxone-resistant vocal cord closure: target validation and development of opioid overdose treatments using a peer-reviewed animal model. | $324K | — |
| Feb 3, 2022 | NIH | STTR Phase I I-Corps Project plan for:STTR Phase I Development of therapeutics to treat fentanyl overdose using a validated animal model | $55K | — |
| Sep 22, 2021 | NIH | STTR Phase I Development of therapeutics to treat fentanyl overdose using a validated animal model | $320K | — |
Peer ranks
Federal funding#242
Awards as PI#117
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.